What this site is — and is not

IOL Adviser translates technical and clinical information about cataract surgery and intraocular lenses into practical questions for patients. It does not diagnose disease, determine medical suitability, prescribe a lens or replace an examination by a qualified ophthalmologist or surgeon.

How sources are selected

We prioritize regulatory documents, peer-reviewed studies, systematic reviews, professional-society guidance and clearly identified manufacturer technical data. Marketing claims, clinic pages, testimonials and social-media reports may help identify patient concerns, but they are not treated as equivalent to clinical evidence.

Bench data and clinical outcomes are different

Optical-bench measurements can explain how an IOL design behaves under controlled conditions. They cannot by themselves predict one person’s visual experience. Clinical studies add information about real patients, but results still depend on study design, patient selection, ocular health, surgical technique and follow-up.

Benefits, limitations and targets the study did not meet

A review starts with the exact model, the lens it was compared with, what the study was designed to measure, the test conditions and the follow-up period. We report a demonstrated benefit plainly. We also report a demonstrated limitation or a target the study did not meet plainly. We do not invent a downside merely to make every conclusion sound balanced, and we do not turn a category label into a claim about every lens in that category.

Critical claims about competing products receive a second source check. The same scrutiny applies to every manufacturer. A review that makes a strong claim without an identifiable source does not pass publication review.

Authorship, commercial context and corrections

Oleksii remains a co-owner of Technomedex Group. His professional biography explains this commercial context alongside his experience in ophthalmic technology.

Pages carrying Oleksii Sologub’s byline are based on his original material or contain his substantive analysis, and he accepts editorial responsibility for them. New technical terms are explained in ordinary language or linked to a page where that explanation already exists. Figurative explanations are used only when they come from Oleksii’s own teaching corpus; the editorial process does not manufacture a new metaphor in his name.

Pages labelled “IOL Adviser” are editorial resources prepared for the project and are not presented as Oleksii’s personal writing. AI tools may assist with drafting, translation or editing; they are not listed as authors. Neither form of attribution implies a personal medical assessment or replaces review by your treating clinician.

Pages show an update date only when the content has been substantively reviewed. If you find a factual error, a broken source or an important new study, please use the contact form linked in the footer so the claim can be checked and corrected.

How to use the information safely

Use IOL Adviser to understand terminology, identify your visual priorities and prepare questions. Bring those questions, together with your examination and measurements, to the surgeon responsible for your care. The final medical decision belongs to you and that qualified clinician.

Meet the authorIOL consultation